• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Update from CDER, FDA/CMS meeting December 9, 2010

Dr. Janet Woodcock, Director, Center for Drug Evaluation & Research at the FDA, reviews 2010 initiatives and details 2011 public health priorities to biopharma executives at the FDA/CMS Summit in Washington, DC.